Form 8-K - Current report:
SEC Accession No. 0001193125-20-240118
Filing Date
2020-09-04
Accepted
2020-09-04 16:31:07
Documents
19
Period of Report
2020-09-04
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 1.02: Termination of a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d65166d8k.htm   iXBRL 8-K 190046
2 EX-5.1 d65166dex51.htm EX-5.1 36817
3 EX-10.1 d65166dex101.htm EX-10.1 206887
4 EX-23.1 d65166dex231.htm EX-23.1 2385
5 EX-99.1 d65166dex991.htm EX-99.1 196054
9 GRAPHIC g65166g32q22.jpg GRAPHIC 140993
10 GRAPHIC g65166g50n77.jpg GRAPHIC 139636
11 GRAPHIC g65166g63l92.jpg GRAPHIC 162312
  Complete submission text file 0001193125-20-240118.txt   2003303

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA fbrx-20200904.xsd EX-101.SCH 3084
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE fbrx-20200904_lab.xml EX-101.LAB 18887
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE fbrx-20200904_pre.xml EX-101.PRE 11869
12 EXTRACTED XBRL INSTANCE DOCUMENT d65166d8k_htm.xml XML 3484
Mailing Address 1124 W CARSON STREET MRL BUILDING 3-320 TORRANCE CA 90502
Business Address 1124 W CARSON STREET MRL BUILDING 3-320 TORRANCE CA 90502 (310) 618-6994
Forte Biosciences, Inc. (Filer) CIK: 0001419041 (see all company filings)

IRS No.: 261243872 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38052 | Film No.: 201162142
SIC: 2834 Pharmaceutical Preparations